Insulin Resistance
21 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Glucose Metabolism Disorders, Metabolic Diseases
Narrower: Metabolic Syndrome 12
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Beta glucan for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bread with added beta-glucans for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Calorie restricted diet and exercise intervention for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| cfMSC therapy for diabetes for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| delayed APM group recruit participants with symptoms lasting for more than 6 months for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diet-as-Usual (DAU) + LCHF Ketogenic Diet for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Early arthroscopic partial menisectomy group for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| fecal microbiota transplantation from healthy lean donors for metabolic syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Green coffee + beta-glucan for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Green coffee extract for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-intensity Mediterranean diet intervention for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hyperpolarized 13C-pyruvate for metabolic syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Insulin efsitora alfa for insulin resistance | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| libitum diet and waiting list control group for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Metreleptin for insulin resistance | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment. for metabolic syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Relacorilant for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for insulin resistance | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for metabolic syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.